The administration of peripheral vasodilators produces hemodynamic and clinical improvement in patients with refractory congestive heart fialure. The responses to these agents in our experience, however, has varied greatly. Our previous work has established at least 3 determinant factors of importance in modulating the responses observed: (1) the dose of the vasodilator agent; (2) the degree of preservation of compensatory mechanisms which are activated by and serve to counteract the peripheral vasodilation; (3) the subvalvular left ventricular end-diastotic dimension which reflects either ventricular volume or the severity of mitral regurgitation. We propose to examine the mechanisms behind these determinant factors, how they interact to modulate the responses observed and to evaluate if other factors are operative as well. Fifty patients with severe heart failure will be evaluated by invasive hemodynamic monitoring. Each will receive 3 vasodilator drugs (hydralazine, nitroglycerin and nitroprusside) intravenously and in stepwise increments to permit construction of dose response curves. Hemodynamic variables, ventricular and regurgitant volumes, plasma catecholamines and renin activity and plasma levels of 6-keto-PGF-1 alpha will be determined prior to and during therapy; Differences in the responses observed will be analyzed in terms of variations in the determinant factors before and after therapy. Determinant factors will then be enhanced or depressed by trimethophan camsylate, phenylephrine, indomethacin or teprotide and the administration of vasodilator agents repeated; the resultant shifts in the dose response curves will be related to changes in the determinant factors. In this way, we will be able to identify specific factors (systolic and diastolic wall stress, radionuclide regurgitant fraction, neurohumoral states) which can determine the response to vasodilators in human heart failure and can be utilized clinically in selecting those patients most likely to respond favorably to vasodilator therapy.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL025055-05
Application #
3337949
Study Section
Cardiovascular and Pulmonary Research B Study Section (CVB)
Project Start
1980-06-01
Project End
1987-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
5
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Packer, M (1992) Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation 85:I50-6
Packer, M; Kukin, M L (1991) Management of patients with heart failure and angina: do coexistent diseases alter the response to cardiovascular drugs? J Am Coll Cardiol 17:740-2
Neuberg, G W; Kukin, M L; Penn, J et al. (1991) Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure. Am J Cardiol 67:63-6
Haber, H L; Leavy, J A; Kessler, P D et al. (1991) The erythrocyte sedimentation rate in congestive heart failure. N Engl J Med 324:353-8
Gottlieb, S S; Kukin, M L; Medina, N et al. (1990) Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure. Circulation 81:860-4
Packer, M (1990) The placebo effect in heart failure. Am Heart J 120:1579-82
Gottlieb, S S; Baruch, L; Kukin, M L et al. (1990) Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J Am Coll Cardiol 16:827-31
Packer, M (1990) Diastolic function as a target of therapeutic interventions in chronic heart failure. Eur Heart J 11 Suppl C:35-40
Packer, M (1990) What causes tolerance to nitroglycerin? The 100 year old mystery continues. J Am Coll Cardiol 16:932-5
Packer, M (1990) Why do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting-enzyme inhibition. Eur Heart J 11 Suppl D:44-52

Showing the most recent 10 out of 33 publications